Quest Diagnostics (DGX) Short term Debt (2009 - 2026)

Quest Diagnostics has disclosed Short term Debt across 18 years of filings, most recently posting $10.0 million for Q2 2026.

• In Q2 2026, Short term Debt fell 98.02% year-over-year to $10.0 million; the TTM figure through Jun 2026 stood at $10.0 million (down 98.02% YoY), while the FY2025 annual figure was $504.0 million, down 16.28% from the prior year.
• Short term Debt came in at $10.0 million for Q2 2026 at Quest Diagnostics, down from $503.0 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $906.0 million in Q1 2024 to a low of $1.0 million in Q1 2025.
• Average Short term Debt over 5 years is $326.6 million, with a median of $403.5 million recorded in 2023.
• Year-over-year, Short term Debt sank 99.89% in 2025 and surged 50200.0% in 2026.
• Over 5 years, Short term Debt stood at $2.0 million in 2022, then soared by 15050.0% to $303.0 million in 2023, then surged by 98.68% to $602.0 million in 2024, then declined by 16.28% to $504.0 million in 2025, then sank by 98.02% to $10.0 million in 2026.
• Per Business Quant data, the three most recent Short term Debt figures were $10.0 million in Q2 2026, $503.0 million in Q1 2026, and $504.0 million in Q4 2025.